(function(){ var content_array=["

鍏充簬Eyenovia<\/b>鍏徃<\/b><\/p> \n

Eyenovia, Inc.锛堢撼鏂揪鍏嬭偂绁ㄤ唬鐮侊細EYEN锛夋槸涓€瀹朵复搴婇樁娈电殑鐪肩鐢熺墿鍒惰嵂鍏徃锛岃嚧鍔涗簬寮€鍙戝熀浜嶮AP鈩� 锛圡icrodose Array Print锛夋妧鏈钩鍙扮殑浜у搧绠＄嚎銆侲yenovia鍏徃褰撳墠鐨勭爺鍙戠绾夸笓娉ㄤ簬鐢ㄤ簬鑰佽銆佽繎瑙嗚繘灞曞強鎵╃灣鐨勫井鍓傞噺鑽墿鐨勪复搴婂悗鏈熷紑鍙戙€傛洿澶氫俊鎭紝璇疯闂�www.eyenovia.com<\/a>銆�<\/p> \n

鍏充簬鏋佺洰鐢熺墿<\/b><\/p> \n

鏋佺洰鐢熺墿鏄竴瀹朵复搴婂紑鍙戦樁娈电殑鐪肩鐢熺墿鎶€鏈叕鍙革紝鎷ユ湁涓€绯诲垪绐佺牬鎬х溂绉戞不鐤楁妧鏈骇鍝佺粍鍚堛€傚叕鍙哥殑鎰挎櫙鏄紝閫氳繃鍦ㄤ腑鍥姐€佷簹娲蹭箖鑷冲叏鐞冩彁渚涘垱鏂扮枟娉曪紝瑙ｅ喅鐪肩鐤剧梾棰嗗煙鏈弧瓒崇殑鍖荤枟闇€姹傘€傛瀬鐩敓鐗╁湪椤剁骇鐢熷懡绉戝鎶曡祫鏂圭殑鏀寔涓嬪垱绔嬶紝骞剁敱涓€鏀嫢鏈夊湪鍏ㄧ悆鍙婁腑鍥界爺鍙戝拰鍟嗕笟鍖栫溂绉戜骇鍝佷赴瀵屽崜瓒婄粡楠岀殑琛屼笟绮捐嫳鍥㈤槦棰嗗绠＄悊銆傛湁鍏虫洿澶氫俊鎭紝璇疯闂�https:\/\/www.arcticvision.com<\/a>銆�<\/p> \n

鏋佺洰鐢熺墿濯掍綋鑱旂郴:
<\/b>communications@arcticvision.com<\/a><\/p> \n

 <\/p> \n

鎷撳睍闃呰锛�<\/b><\/p> \n

1.  Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia<\/a>
2.  鏋佺洰鐢熺墿涓嶦yenovia瀹ｅ竷灏盡icroPine鍜孧icroLine杈炬垚鐙璁稿彲鍗忚灏嗗湪澶т腑鍗庡尯鍜岄煩鍥藉紑鍙戝強鍟嗕笟鍖栫溂绉戝垱鏂扮枟娉�<\/a>
3.  Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, clearing Path to Initiate Phase 3 Vision Trial by Year End<\/a><\/p> \n

\n<\/div>"]; $("#dvExtra").html(content_array[0]);})();